Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Shefferman Jesse Create: Alert

All | News | Filings
Date FiledTypeDescription
02/10/2023 5 Form 5 - Annual statement of changes in beneficial ownership of securities:
01/20/2023 4 Shefferman Jesse (CEO and President) has filed a Form 4 on Protara Therapeutics, Inc.
Txns: Granted 51,300 shares @ $0
Granted 307,500 options to buy @ $3.02, valued at $928.7k
01/11/2023 4 Shefferman Jesse (CEO and President) has filed a Form 4 on Protara Therapeutics, Inc.
Txns: Paid exercise price by delivering 5,855 shares @ $3, valued at $17.6k
01/04/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/11/2022 5 Form 5 - Annual statement of changes in beneficial ownership of securities:
01/12/2022 4 Shefferman Jesse (CEO and President) has filed a Form 4 on Protara Therapeutics, Inc.
Txns: Paid exercise price by delivering 5,080 shares @ $6.27, valued at $31.9k
01/05/2022 4 Shefferman Jesse (CEO and President) has filed a Form 4 on Protara Therapeutics, Inc.
Txns: Granted 42,300 shares @ $0
Granted 253,500 options to buy @ $6.9, valued at $1.7M
01/21/2021 4 Shefferman Jesse (CEO and President) has filed a Form 4 on Protara Therapeutics, Inc.
Txns: Granted 202,000 options to buy @ $19.82, valued at $4M
01/13/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/13/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/18/2020 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
01/13/2020 4 Shefferman Jesse (CEO and President) has filed a Form 4 on ArTara Therapeutics, Inc.
Txns: Granted 790,274 shares @ $0
Granted 50,000 shares @ $0
Granted 111,250 options to buy @ $31.5, valued at $3.5M
01/13/2020 3 Shefferman Jesse (CEO and President) has filed a Form 3 on ArTara Therapeutics, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy